Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine for maintenance of sinus rhythm after electrical cardioversion in atrial fibrillation (Phase II, dose-ranging)
2011-002789-18Phase 2Completed
- Sponsor
- Menarini Ricerche
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ranolazine in Atrial fibrillation (AFib) (4 arms), sponsored by Menarini Ricerche. Primary endpoint: Time to first documented atrial fibrillation recurrence. Started Aug 2011; status: completed.
02
Drugs
ranolazine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2011-002789-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002789-18.